Archive - January 2023
Eli Lilly to help fund cold chain initiative
COVID-19 Vaccine: 57 % Completely, 10% Partially Vaccinated, Says NPHCDA
Orbsen announces results from Nephstrom trial
DSVA Empowers 104 High-Risk Gender-Based Violence Survivors
NICE recommends Alexion’s asfotase alfa across England
New UK point of care manufacturing regulatory framework
Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
JCVI recommends autumn COVID-19 vaccine booster for those at highest risk